These data show that the magnitude of the effect of APOE4 on Alzheimer’s disease is more similar to the one observed for major genes in Mendelian diseases such as BRCA1 in breast cancer than to low-risk common alleles identified by recent genome-wide association studies in complex diseases13. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.